PROM1 and chronic obstructive pulmonary disease: Many studies [6,27,35,61,65–67] have used CD34+KDR+ or CD34+KDR+CD133+ cells to study COPD, coming to different conclusions based on the characterization of the EPCs, and few have examined COPD subphenotypes.